Thermo Fisher Scientific (TMO) Change in Cash (2009 - 2026)

Thermo Fisher Scientific (TMO) has reported Change in Cash for 18 consecutive years, with $817.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Change in Cash rose 89.56% year-over-year to $817.0 million; the trailing twelve-month figure through Jun 2026 stood at -$506.0 million (up 79.71% YoY), and the FY2025 full-year result was $5.8 billion, up 243.92% from the prior year.
• Change in Cash improved to $817.0 million in Q2 2026 per TMO's latest filing, from -$6.6 billion in the prior quarter.
• Across five years, Change in Cash topped out at $7.9 billion in Q4 2025 and bottomed at -$6.6 billion in Q1 2026.
• Historically, Change in Cash has averaged -$21.9 million across 5 years, with a median of -$107.5 million in 2023.
• The sharpest annual moves came in 2025 and 2026: Change in Cash surged 1348.89% in 2025, then tumbled 5099.24% in 2026.
• Over 5 years, Change in Cash stood at $5.6 billion in 2022, then sank by 65.57% to $1.9 billion in 2023, then tumbled by 132.66% to -$630.0 million in 2024, then soared by 1348.89% to $7.9 billion in 2025, then slumped by 89.62% to $817.0 million in 2026.
• According to Business Quant data, Change in Cash over the past three periods registered $817.0 million, -$6.6 billion, and $7.9 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.